等待開盤 09-08 09:30:00 美东时间
+0.140
+0.42%
Analysts are intrested in these 5 stocks: ( ($RCAT) ), ( ($USAR) ), ( ($QURE) )...
09-05 17:01
今日重点评级关注:BTIG:维持Climb Bio"买入"评级,目标价从20美元升至32美元;巴克莱:维持Alpha Tau Medical"超配"评级,目标价从17美元升至30美元
09-04 12:30
JP Morgan analyst Jash Patwa upgrades Copart (NASDAQ:CPRT) from Neutral to Overweight and raises the price target from $32 to $40.
09-04 05:00
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.5美元升至6美元;Ascendiant Capital:维持Quantum Computing"买入"评级,目标价从30美元升至32美元
08-27 08:37
经济观察网 科帕特(CPRT)8月20日盘后数据显示股价创60日新高,当前多头动能有所增强。 8月20日盘后资讯提示"创60日新高、多头动能增强" . 以上内容...
08-24 01:10
The Nasdaq Composite Index (COMP:IND) closed flat but in the green on Friday in tandem with other indexes on Wall Street, as Bitcoin (BTC-USD) fluctuated sharply as it extended a volatile rebound from...
08-22 04:20
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
Stephens & Co. analyst Jeff Lick reiterates Copart (NASDAQ:CPRT) with a Equal-Weight and maintains $35 price target.
08-20 21:07
• 受超卖修复、机构买盘及板块动能推动,Copart 股价强劲上涨。 • 有力的高管层调整与股票回购举措进一步巩固了投资者对基本面的信心。 • 全年营收达 46.5 亿美元,净利润为 15.5 亿美元。
08-14 18:15
• Copart surged due to oversold conditions, institutional buying, and sector momentum. • Strong leadership changes and share repurchase activity reinforced fundamental investor sentiment. • Annual revenue reached $4.65 billion with net profit at $1.55 billion.
08-14 18:15